Literature DB >> 15579443

Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis.

Enrico Lupia1, Alberto Goffi, Paolo De Giuli, Ornella Azzolino, Ornella Bosco, Enrico Patrucco, Maria Cristina Vivaldo, Marco Ricca, Matthias P Wymann, Emilio Hirsch, Giuseppe Montrucchio, Giorgio Emanuelli.   

Abstract

In pancreatic acini, the G-protein-activated phosphoinositide 3-kinase-gamma (PI3K gamma) regulates several key pathological responses to cholecystokinin hyperstimulation in vitro. Thus, using mice lacking PI3K gamma, we studied the function of this enzyme in vivo in two different models of acute pancreatitis. The disease was induced by supramaximal concentrations of cerulein and by feeding mice a choline-deficient/ethionine-supplemented diet. Although the secretive function of isolated pancreatic acini was identical in mutant and control samples, in both models, genetic ablation of PI3K gamma significantly reduced the extent of acinar cell injury/necrosis. In agreement with a protective role of apoptosis in pancreatitis, PI3K gamma-deficient pancreata showed an increased number of apoptotic acinar cells, as determined by terminal dUTP nick-end labeling and caspase-3 activity. In addition, neutrophil infiltration within the pancreatic tissue was also reduced, suggesting a dual action of PI3K gamma, both in the triggering events within acinar cells and in the subsequent neutrophil recruitment and activation. Finally, the lethality of the choline-deficient/ethionine-supplemented diet-induced pancreatitis was significantly reduced in mice lacking PI3K gamma. Our results thus suggest that inhibition of PI3K gamma may be of therapeutic value in acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579443      PMCID: PMC1618701          DOI: 10.1016/s0002-9440(10)63251-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  Lipids on the move: phosphoinositide 3-kinases in leukocyte function.

Authors:  M P Wymann; S Sozzani; F Altruda; A Mantovani; E Hirsch
Journal:  Immunol Today       Date:  2000-06

Review 2.  Growth factor signaling in cell survival: implications for cancer treatment.

Authors:  S Talapatra; C B Thompson
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

3.  Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis.

Authors:  V P Singh; A K Saluja; L Bhagat; G J van Acker; A M Song; S P Soltoff; L C Cantley; M L Steer
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Cd40 ligand-deficient mice are protected against cerulein-induced acute pancreatitis and pancreatitis-associated lung injury.

Authors:  J L Frossard; B Kwak; M Chanson; P Morel; A Hadengue; F Mach
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

5.  Involvement of phosphoinositide 3-kinase and its association with pp60src in cholecystokinin-stimulated pancreatic acinar cells.

Authors:  F Nozu; C Owyang; Y Tsunoda
Journal:  Eur J Cell Biol       Date:  2000-11       Impact factor: 4.492

6.  Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells.

Authors:  S Charland; M J Boucher; M Houde; N Rivard
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

7.  Resistance to thromboembolism in PI3Kgamma-deficient mice.

Authors:  E Hirsch; O Bosco; P Tropel; M Laffargue; R Calvez; F Altruda; M Wymann; G Montrucchio
Journal:  FASEB J       Date:  2001-07-09       Impact factor: 5.191

8.  Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells.

Authors:  M Raraty; J Ward; G Erdemli; C Vaillant; J P Neoptolemos; R Sutton; O H Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

9.  Phosphatidylinositide 3-kinase gamma regulates key pathologic responses to cholecystokinin in pancreatic acinar cells.

Authors:  Ilya Gukovsky; Jason H Cheng; Kyung J Nam; Oliver T Lee; Aurelia Lugea; Lars Fischer; Josef M Penninger; Stephen J Pandol; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 10.  Apoptosis versus necrosis in acute pancreatitis.

Authors:  Madhav Bhatia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02       Impact factor: 4.052

View more
  23 in total

1.  Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation.

Authors:  Chandra Durgampudi; Pawan Noel; Krutika Patel; Rachel Cline; Ram N Trivedi; James P DeLany; Dhiraj Yadav; Georgios I Papachristou; Kenneth Lee; Chathur Acharya; Deepthi Jaligama; Sarah Navina; Faris Murad; Vijay P Singh
Journal:  Am J Pathol       Date:  2014-06       Impact factor: 4.307

2.  Duration of injury correlates with necrosis in caerulein-induced experimental acute pancreatitis: implications for pathophysiology.

Authors:  Tony G Jacob; Rahul Raghav; Ajay Kumar; Pramod K Garg; Tara S Roy
Journal:  Int J Exp Pathol       Date:  2014-04-25       Impact factor: 1.925

3.  Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.

Authors:  Simon Hohenester; Anna Gates; Ralf Wimmer; Ulrich Beuers; M Sawkat Anwer; Christian Rust; Cynthia R L Webster
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

4.  PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.

Authors:  Chia-Yen C Wu; Eileen S Carpenter; Kenneth K Takeuchi; Christopher J Halbrook; Louise V Peverley; Harold Bien; Jason C Hall; Kathleen E DelGiorno; Debjani Pal; Yan Song; Chanjuan Shi; Richard Z Lin; Howard C Crawford
Journal:  Gastroenterology       Date:  2014-08-27       Impact factor: 22.682

5.  PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis.

Authors:  Xiao Li Huang; Jin Xu; Xiao Hui Zhang; Bo Yun Qiu; Lan Peng; Meng Zhang; Hua Tian Gan
Journal:  Inflamm Res       Date:  2011-03-26       Impact factor: 4.575

6.  Glycosylation alterations in acute pancreatitis and pancreatic cancer: CA19-9 expression is involved in pathogenesis and maybe targeted by therapy.

Authors:  Ionut Negoi; Mircea Beuran; Sorin Hostiuc; Massimo Sartelli; Alaa El-Hussuna; Enrique de-Madaria
Journal:  Ann Transl Med       Date:  2019-12

7.  Docosahexaenoic acid inhibits zymogen activation by suppressing vacuolar ATPase activation in cerulein-stimulated pancreatic acinar cells.

Authors:  Yeeun Park; Leeyeon Ku; Joo Weon Lim; Hyeyoung Kim
Journal:  Genes Nutr       Date:  2020-03-23       Impact factor: 5.523

8.  Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.

Authors:  Yaqing Zhang; Wei Yan; Meredith A Collins; Filip Bednar; Sabita Rakshit; Bruce R Zetter; Ben Z Stanger; Ivy Chung; Andrew D Rhim; Marina Pasca di Magliano
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

9.  Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.

Authors:  Christoph W Michalski; Tamara Laukert; Danguole Sauliunaite; Pál Pacher; Frank Bergmann; Nitin Agarwal; Yun Su; Thomas Giese; Nathalia A Giese; Sándor Bátkai; Helmut Friess; Rohini Kuner
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

Review 10.  Elucidating the role of reversible protein phosphorylation in sepsis-induced myocardial dysfunction.

Authors:  Angela Lorts; Timothy Burroughs; Thomas P Shanley
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.